Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Article Views are the COUNTER-compliant sum of full text article downloads since ...
Anish Patel, the Chief Operating Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), recently sold a total of $90,686 worth of company stock, according to the latest SEC filings. The transactions, ...
Portions of Pennsylvania Street in Longview will be closed for the next month as contractors install utilities at the site of the future affordable housing complex Sunrise Village. Starting ...
SEATTLE — During the month of April, several local organizations and families take the opportunity to raise awareness about the complex neurological disorder that typically appears in the first ...
However, to continue transitioning toward individually-tailored care, we require integration of complex ... integrative neuroinformatics platforms are required to drive precision prognostication and ...
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the ... Clairvoyant's randomized controlled trial, CLA-PSY-201, has dosed more than 90 per cent of ...
Clairvoyant on target for potential commercialization of psilocybin treatment in 2025 VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics ... dosed more than 90 per cent of ...
The annual Survey on OTC Counselling and Recommendations is an important pharmaceutical industry indicator which tracks pharmacist and physician counselling patterns for over-the-counter (OTC) ...
Clairvoyant on target for potential commercialization of psilocybin treatment in 2025 VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics Inc. ( www.clairvoyantrx.com), the ...
Acorda Therapeutics shares are trading lower by 87% during Tuesday's session. The company on Monday provided a series of business updates. Loading... Loading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results